HBM Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for HBM Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Take Care Before Jumping Onto HBM Holdings Limited (HKG:2142) Even Though It's 28% Cheaper
Apr 12
HBM Holdings Limited (HKG:2142) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Jan 01We're Not Very Worried About HBM Holdings' (HKG:2142) Cash Burn Rate
Feb 08HBM Holdings (HKG:2142) Is In A Strong Position To Grow Its Business
May 30Revenue Downgrade: Here's What Analysts Forecast For HBM Holdings Limited (HKG:2142)
Apr 07Here's What Analysts Are Forecasting For HBM Holdings Limited (HKG:2142) After Its Full-Year Results
Mar 31What Type Of Shareholders Own The Most Number of HBM Holdings Limited (HKG:2142) Shares?
Mar 10In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HBM Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 90 | 23 | N/A | N/A | N/A |
| 9/30/2023 | 72 | -19 | N/A | N/A | N/A |
| 6/30/2023 | 54 | -61 | -64 | -56 | N/A |
| 3/31/2023 | 47 | -99 | -91 | -78 | N/A |
| 12/31/2022 | 41 | -137 | -118 | -100 | N/A |
| 9/30/2022 | 35 | -143 | -120 | -98 | N/A |
| 6/30/2022 | 30 | -149 | -122 | -97 | N/A |
| 3/31/2022 | 17 | -144 | -131 | -111 | N/A |
| 12/31/2021 | 4 | -138 | -140 | -126 | N/A |
| 9/30/2021 | 7 | -224 | -114 | -106 | N/A |
| 6/30/2021 | 10 | -310 | -88 | -87 | N/A |
| 3/31/2021 | 12 | -303 | -62 | -61 | N/A |
| 12/31/2020 | 14 | -296 | -36 | -35 | N/A |
| 9/30/2020 | 13 | -187 | -41 | -38 | N/A |
| 6/30/2020 | 11 | -78 | -45 | -42 | N/A |
| 3/31/2020 | 8 | -73 | -52 | -44 | N/A |
| 12/31/2019 | 5 | -67 | -59 | -46 | N/A |
| 12/31/2018 | 1 | -35 | -38 | -33 | N/A |
Analyst Future Growth Forecasts
Revenue vs Market: Insufficient data to determine if 2142's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 2142's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2142's Return on Equity is forecast to be high in 3 years time